Biological effectiveness of antiproton annihilation

Mostrar otras versiones (1)

We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in “biological dose” in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Holzscheiter, Michael H., Agazaryan, Nzhde, Bassler, Niels, Beyer, Gerd, De Marco, John J., Doser, Michael, Ichioka, Toshiyasu, Iwamoto, Keisuke S., Knudsen, Helge V., Landua, Rolf, Maggiore, Carl, McBride, William H., Møller, Søren Pape, Petersen, Jorgen, Smathers, James B., Skarsgard, Lloyd D., Solberg, Timothy D., Uggerhøj, Ulrik I., Withers, H.Rodney, Vranjes, Sanja, Wong, Michelle, Wouters, Bradly G.
Lenguaje:eng
Publicado: 2004
Materias:
Health Physics and Radiation Effects
Acceso en línea:https://dx.doi.org/10.1016/j.nimb.2004.03.057
http://cds.cern.ch/record/2040702
Descripción
Sumario:We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in “biological dose” in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The experiment has been approved by the CERN Research Board for running at the CERN Antiproton Decelerator (AD) as AD-4/ACE (Antiproton Cell Experiment) and has begun data taking in June of 2003. The background, description and the current status of the experiment are given.

Ejemplares similares